Model helps predict which patients will benefit most from PSMA PET scan
Targeted elimination of leukemic stem cells
16 February 2021Study examines variation in intensity of fracture-associated prescription drug use
16 February 2021Model helps predict which patients will benefit most from PSMA PET scan
A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center helps identify which patients with prostate cancer will benefit most from the use of prostate-specific membrane antigen PET imaging, PSMA PET, a novel imaging technique that recently was approved by the U.S. Food and Drug Administration.
